Laurence Brunet (L Brunet)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Chronic Kidney Disease

Editorial Comment

Platelet Rich Plasma

Hiv Infected Patients

Top Venues

Journal of the International Association of Providers of AIDS Care

AIDS research and human retroviruses

Open forum infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Michael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, Javeed Siddiqui, Michael Harbour, Amy L Phillips, Brooke Hayward, Jennifer S Fusco, Ricky K Hsu, Gregory P Fusco
Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART Era. AIDS research and human retroviruses (2024)
Gerald Pierone, Laurence Brunet, Jennifer S Fusco, Cassidy E Henegar, Supriya Sarkar, Jean Van Wyk, Vani Vannappagari, Michael B Wohlfeiler, Gregory P Fusco
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care. HIV/AIDS (Auckland, N.Z.) 16 (2024)
Michael B Wohlfeiler, Laurence Brunet, Quateka Cochran, Jennifer S Fusco, Ricky K Hsu, Gregory P Fusco
Improving Adherence to the Target Window for Cabotegravir + Rilpivirine Long-Acting Injections Through the CHORUS™ App and Web Portal: A Cluster Randomized Trial. Journal of the International Association of Providers of AIDS Care 23 (2024)
Gerald Pierone, Laurence Brunet, Jennifer S Fusco, Cassidy E Henegar, Supriya Sarkar, Jean Van Wyk, Vani Vannappagari, Michael B Wohlfeiler, Gregory P Fusco
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care. HIV/AIDS (Auckland, N.Z.) 16 (2024)
Gerald Pierone, Laurence Brunet, Jennifer S Fusco, Cassidy E Henegar, Supriya Sarkar, Jean Van Wyk, Vani Vannappagari, Michael B Wohlfeiler, Gregory P Fusco
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care. HIV/AIDS (Auckland, N.Z.) 16 (2024)
Michael B Wohlfeiler, Laurence Brunet, Quateka Cochran, Jennifer S Fusco, Ricky K Hsu, Gregory P Fusco
Improving Adherence to the Target Window for Cabotegravir + Rilpivirine Long-Acting Injections Through the CHORUS™ App and Web Portal: A Cluster Randomized Trial. Journal of the International Association of Providers of AIDS Care 23 (2024)
Michael B Wohlfeiler, Laurence Brunet, Quateka Cochran, Jennifer S Fusco, Ricky K Hsu, Gregory P Fusco
Improving Adherence to the Target Window for Cabotegravir + Rilpivirine Long-Acting Injections Through the CHORUS™ App and Web Portal: A Cluster Randomized Trial. Journal of the International Association of Providers of AIDS Care 23 (2024)
Michael B Wohlfeiler, Laurence Brunet, Quateka Cochran, Jennifer S Fusco, Ricky K Hsu, Gregory P Fusco
Improving Adherence to the Target Window for Cabotegravir + Rilpivirine Long-Acting Injections Through the CHORUS™ App and Web Portal: A Cluster Randomized Trial. Journal of the International Association of Providers of AIDS Care 23 (2024)
Michael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, Javeed Siddiqui, Michael Harbour, Amy L Phillips, Brooke Hayward, Jennifer S Fusco, Ricky K Hsu, Gregory P Fusco
Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART Era. AIDS research and human retroviruses 40 (7) (2024)
Ricky K Hsu, Laurence Brunet, Philip C Lackey, Gerald Pierone, Brooke Levis, Jennifer S Fusco, Cassidy Henegar, Vani Vannappagari, Andrew Clark, Gregory P Fusco
Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study. HIV medicine (2024)
Karam Mounzer, Laurence Brunet, Jennifer S Fusco, Ian R McNicholl, Megan Dunbar, Michael Sension, Lewis H McCurdy, Gregory P Fusco
Immune response to ART initiation in advanced HIV infection. HIV medicine (2023)
Michael G Sension, Laurence Brunet, Ricky K Hsu, Jennifer S Fusco, Quateka Cochran, Christine Uranaka, Gayathri Sridhar, Vani Vannappagari, Jean Van Wyk, Lewis McCurdy, Michael B Wohlfeiler, Gregory P Fusco
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort. Infectious diseases and therapy (2023)
Karam Mounzer, Laurence Brunet, Jennifer S Fusco, Ian R Mcnicholl, Helena Diaz Cuervo, Michael Sension, Lewis Mccurdy, Gregory P Fusco
Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens. Open forum infectious diseases 9 (3) (2022)
Ricky K Hsu, Laurence Brunet, Jennifer S Fusco, Karam Mounzer, Joyce C LaMori, Gregory P Fusco
Excessive Weight Gain: Current Antiretroviral Agents in Virologically Suppressed People with HIV. AIDS research and human retroviruses 38 (10) (2022)
Patrick W G Mallon, Laurence Brunet, Jennifer S Fusco, Girish Prajapati, Andrew Beyer, Gregory P Fusco, Michael B Wohlfeiler
Lipid Changes After Switch From TDF to TAF in the OPERA Cohort: LDL Cholesterol and Triglycerides. Open forum infectious diseases 9 (1) (2021)
Laurence Brunet, Patrick W G Mallon, Jennifer S Fusco, Michael B Wohlfeiler, Girish Prajapati, Andrew Beyer, Gregory P Fusco
Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization. Clinical drug investigation 41 (11) (2021)
Anthony M Mills, Kathy L Schulman, Jennifer S Fusco, Michael B Wohlfeiler, Julie L Priest, Alan Oglesby, Laurence Brunet, Philip C Lackey, Gregory P Fusco
Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents. Open forum infectious diseases 8 (8) (2021)
Karam Mounzer, Laurence Brunet, Ricky Hsu, Jennifer S Fusco, Vani Vannappagari, Cassidy Henegar, Jean van Wyk, Melissa Crawford, Janet Lo, Gregory Fusco
Changes in Body Mass Index Associated with Antiretroviral Regimen Switch Among Treatment-Experienced, Virologically Suppressed People Living with HIV in the United States. AIDS research and human retroviruses 37 (11) (2021)
Patrick W G Mallon, Laurence Brunet, Ricky K Hsu, Jennifer S Fusco, Karam C Mounzer, Girish Prajapati, Andrew P Beyer, Michael B Wohlfeiler, Gregory P Fusco
Weight gain before and after switch from TDF to TAF in a U.S. cohort study. Journal of the International AIDS Society 24 (4) (2021)
Michael Wohlfeiler, Karam Mounzer, Laurence Brunet, Jennifer S Fusco, Vani Vannappagari, Lloyd Curtis, Nassrin Payvandi, Michael Aboud, Ricky Hsu, Philip Lackey, Gregory Fusco
Antiretroviral therapy and liver disorders in the OPERA® cohort. Therapeutic advances in drug safety 11 (2020)
A M Mills, K L Schulman, Jennifer S Fusco, Laurence Brunet, R Hsu, A Beyer, G Prajapati, K Mounzer, G P Fusco
Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA. HIV medicine 21 (5) (2020)
R Hsu, Laurence Brunet, Jennifer S Fusco, A Beyer, G Prajapati, C Wyatt, M Wohlfeiler, G Fusco
Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score. HIV medicine 22 (5) (2020)
Anthony M Mills, Laurence Brunet, Jennifer S Fusco, Michael B Wohlfeiler, Cindy P Garris, Alan K Oglesby, Joseph M Mrus, Philip C Lackey, Gregory P Fusco
Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study. Infectious diseases and therapy 9 (1) (2019)